Apolipoprotein L1 Genetic Testing and Counseling Does Not Reduce Living Kidney Donors' Willingness to Donate
Clinical Journal of the American Society of Nephrology · 2026-07 · 21 (7) · 1222-1234
DOI: 10.2215/cjn.0000001064 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Journal of the American Society of Nephrology, online erschienen am 20.04.2026. Verfasst von Elisa J Gordon und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Center for Biomedical Ethics and Society, Vanderbilt University Medical Center, Nashville, Tennessee. Hauptthemen laut MEDLINE: Apolipoprotein L1, Living Donors, Kidney Transplantation, Genetic Testing. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, Northwestern Memorial Hospital, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Key Points Apolipoprotein L1 genetic testing did not reduce potential living donors' willingness to donate, supporting integration of testing into practice. The Apolipoprotein L1 Testing and Counseling Program did not reduce potential living donors' decisional conflict or increase preparedness to donate. The trial demonstrated the feasibility of integrating apolipoprotein L1 genetic testing and counseling into routine living donor clinical evaluation.
Background
Living donors of African ancestry have the highest risk of postdonation kidney disease. Apolipoprotein L1 ( APOL1 ) risk variants may contribute to this risk. This study evaluated the effectiveness and implementation of our culturally appropriate APOL1 Testing and Counseling Program to reduce potential donors' decisional conflict for donation.
Methods
This prospective, nonrandomized, pre-post two-site hybrid type 2 effectiveness-implementation study evaluated the effect of the intervention on decisional conflict about donation, preparedness for decision making about donation and for donation, willingness to donate, and satisfaction with informed consent among potential donors of African ancestry undergoing evaluation. The intervention involved donors: using a chatbot providing APOL1 information, receiving culturally competent counseling, and APOL1 genetic testing. Control arm received routine care. We used the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework to longitudinally evaluate implementation outcomes assessed through validated surveys with donors and electronic health record review using linear mixed effects models. Cross-sectional outcomes were assessed using multiple regression models.
Results
We enrolled 280 potential donors (75 control arm, 205 intervention arm; 71.07% participation rate). More were female (59%) and had a mean age of 40.2 years (SD, 12.8). No significant differences emerged in most primary and secondary outcomes between the intervention and control groups (decisional conflict β [95% confidence interval (CI)], −1.05 [−4.13 to 2.03]; P = 0.50), preparation for decision making ( β [95% CI], −7.02 [−18.83 to 4.78]; P = 0.24), preparedness to donate ( β [95% CI], 0.04 [−0.48 to 0.56]; P = 0.89), willingness to donate ( β [95% CI], 0.18 [−0.29 to 0.66]; P = 0.45). The right amount of information to make a decision domain for satisfaction with informed consent was significantly lower in the intervention arm ( β [95% CI], −0.34 [−0.65 to −0.02]; P = 0.04).
Conclusions
Our APOL1 Testing and Counseling Program had no effect on potential donors' willingness to donate regardless of undergoing APOL1 testing, demonstrating the feasibility of its integration into routine donor clinical evaluation. Clinical Trial registry name and registration number: NCT04910867.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Center for Biomedical Ethics and Society, Vanderbilt University Medical Center, Nashville, Tennessee.
- Center for Health Services and Outcomes Research, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
- Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, Utah.
- Myriad Genetics, Inc., Chicago, Illinois.
- Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
- Medicine, Cardiology Division, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
ORCID-Profile: Elisa J Gordon, Jessica Gacki-Smith, Justin D Smith, Catherine Wicklund, Debra Duquette, Lutfiyya N Muhammad, Bright Yevugah, Griffin Anderson, John Friedewald, Alexander Gilbert, Jacqueline Burgess-Bishop, Marion Shuck, Calmetta Coleman, Akansha Agrawal
Förderung
- NIDDK NIH HHS
- Northwestern Memorial Hospital
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Gordon, E. J., Gacki-Smith, J., Smith, J. D., Wicklund, C., Duquette, D., Muhammad, L. N., Dong, S., Yevugah, B., Anderson, G., Friedewald, J., Gilbert, A., Tandon, S. D., Burgess-Bishop, J., Fox, M., Shuck, M., Binion, P. A., Crawford, V., Coleman, C., Howard, J., & Agrawal, A. (2026). Apolipoprotein L1 Genetic Testing and Counseling Does Not Reduce Living Kidney Donors' Willingness to Donate. Clinical Journal of the American Society of Nephrology, 21(7), 1222-1234. https://doi.org/10.2215/cjn.0000001064
Vancouver
Gordon EJ, Gacki-Smith J, Smith JD, Wicklund C, Duquette D, Muhammad LN, et al. Apolipoprotein L1 Genetic Testing and Counseling Does Not Reduce Living Kidney Donors' Willingness to Donate. Clinical Journal of the American Society of Nephrology. 2026;21(7):1222-1234. doi:10.2215/cjn.0000001064
BibTeX
@article{Gordon2026,
author = {Gordon, Elisa J and Gacki-Smith, Jessica and Smith, Justin D and Wicklund, Catherine and Duquette, Debra and Muhammad, Lutfiyya N and Dong, Siyuan and Yevugah, Bright and Anderson, Griffin and Friedewald, John and Gilbert, Alexander and Tandon, S Darius and Burgess-Bishop, Jacqueline and Fox, Monica and Shuck, Marion and Binion, Phalese A and Crawford, Veatrice and Coleman, Calmetta and Howard, Joann and Agrawal, Akansha},
title = {Apolipoprotein L1 Genetic Testing and Counseling Does Not Reduce Living Kidney Donors' Willingness to Donate},
journal = {Clinical Journal of the American Society of Nephrology},
year = {2026},
volume = {21},
number = {7},
pages = {1222--1234},
doi = {10.2215/cjn.0000001064}
}
EUVIMED